Welcome to Peptidea Insider, your source for company news, new research materials, product development and special announcements.
In this edition, we're highlighting DERMA-X development, introducing newly added research compounds, and sharing the latest updates from Peptidea.
Peptidea is developing a new peptide-based cosmetic toner as part of the DERMA-X collection.
Development includes research involving GHK-Cu, SNAP-8, and selected supporting cosmetic ingredients, with ongoing formulation refinement.
Learn about the ingredient research, preliminary observations, and next development stages.
Read the Full Product Story →
In Development
DERMA-X Night Renewal is being developed as an HPR-containing nighttime cosmetic cream.
Our development journal explores emulsion preparation, ingredient compatibility, prototype observations, and future formulation priorities.
Explore Development Details →
New Research Materials
Peptidea is expanding its research catalog with RC-IPA (Ipamorelin), RC-LIV (Livagen), and RC-ADX (Adamax).
Explore the new materials, research descriptions, and available product listings.
Explore New Arrivals →Peptidea continues to expand its research catalog while developing new ways to share information with the research community.
This month, we're highlighting the progress of DERMA-X Peptide Toner and Night Renewal, introducing recently added research materials, and expanding the Peptidea Insider news and development resources.
Visitors can now explore dedicated development journals to learn more about formulation objectives, preliminary observations, and ongoing product research.
Explore DERMA-X Development →Discover current Peptidea promotions, referral opportunities, and upcoming events.
Peptidea Referral Rewards Program
Our Give 10% • Get 10% referral promotion is a way to introduce fellow researchers to Peptidea.
Share your personal referral code with an eligible researcher. Your referral can receive 10% off a qualifying purchase, while you may earn a 10% referral reward under the program terms.
Eligibility, qualifying purchases, reward issuance, and exclusions are subject to program terms.
Learn More & Register →Upcoming offers and special events.
We're always looking for new ways to keep our research community informed about Peptidea.
Stay connected for future promotional opportunities, special announcements, and upcoming events.
Past Peptidea campaigns will be archived here after their conclusion. Expired promotions will be clearly identified.
October marks continued expansion of the Peptidea research catalog, alongside ongoing development of our DERMA-X collection.
This month's highlights include the DERMA-X Peptide Toner, Night Renewal development, and newly added research materials.
We're also introducing Peptidea Insider as a place to follow company announcements, development updates, and current promotions.
Explore October Highlights →October 2026 Edition — Exploring developments in peptide science, clinical trials, and regulation.
Federal officials submitted an interim policy concerning access to certain compounded peptides for White House review.
The proposal could change aspects of the regulatory environment, but its final provisions and implementation remain uncertain.
Read Reuters Coverage →Eli Lilly released TRIUMPH-2 Phase 3 clinical trial results evaluating investigational retatrutide in adults with obesity or overweight and type 2 diabetes.
The company reported average weight reductions of up to 20.8% over 80 weeks in the studied groups.
Retatrutide remains investigational and is not FDA-approved.
Read Clinical Research Update →The FDA published 17 revised draft product-specific guidances related to peptide drug development.
The updates address scientific and regulatory expectations for generic peptide products, including several established metabolic therapies.
Read FDA Announcement →